Thomas, F. (2023). Optimizing the Manufacture of Emerging Therapies: Guidance for GMP manufacture of emerging therapies has evolved to accommodate innovation and the broader spectrum of products in development, but greater harmonization is still needed...Elena Meurer. Pharmaceutical Technology Europe, 35(5), 31-34.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Thomas, Felicity. "Optimizing the Manufacture of Emerging Therapies: Guidance for GMP Manufacture of Emerging Therapies Has Evolved to Accommodate Innovation and the Broader Spectrum of Products in Development, but Greater Harmonization Is Still Needed...Elena Meurer."
Pharmaceutical Technology Europe 35, no. 5 (2023): 31-34.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Thomas, Felicity. "Optimizing the Manufacture of Emerging Therapies: Guidance for GMP Manufacture of Emerging Therapies Has Evolved to Accommodate Innovation and the Broader Spectrum of Products in Development, but Greater Harmonization Is Still Needed...Elena Meurer."
Pharmaceutical Technology Europe, vol. 35, no. 5, 2023, pp. 31-34.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.